Janssen COVID-19 Vaccine (Johnson & Johnson)

alert icon

CDC and FDA have recommended a pause in the use of the Janssen (Johnson & Johnson) COVID-19 vaccine in the United States out of an abundance of caution, effective Tuesday, April 13. Of the 6.8 million Janssen COVID-19 vaccine doses administered in the United States to date, six cases of a type of blood clot called “cerebral venous sinus thrombosis” (CVST) were seen in combination with low levels of blood platelets (thrombocytopenia). CDC will convene a meeting of the Advisory Committee on Immunization Practices (ACIP) on Wednesday, April 14, to further review these cases and assess their potential significance. FDA will review that analysis as it also investigates these cases.

If you are a COVID-19 Vaccination Provider with Janssen (Johnson & Johnson) vaccine:

  1. Mark any Janssen/J&J vaccine in your inventory “Do not use. Awaiting guidance.”
  2. Continue to store the vaccine in the refrigerator between 2°C and 8°C (36°F and 46°F).
  3. Follow vaccine storage practices and continue to monitor and document storage unit temperatures.
close up of syringe

Dosing information:
Multidose vial: 5 doses per vial
Dosage: 0.5mL
Do NOT mix with a diluent.
Discard vial when there is not enough vaccine to obtain a complete dose. Do NOT combine residual vaccine from multiple vials to obtain a dose.

Age Indications:
18 years of age and older

Schedule:
Single dose

Administration:
Intramuscular (IM) injection in the deltoid muscle

Administration Overview

Before administering vaccine, screen recipients for contraindications and precautions.

To assess patients correctly and consistently, vaccination providers should use a standardized, comprehensive screening tool.

Contraindications and Precautions
How to Prepare and Administer the Janssen Vaccine
laptop solid icon
Document the Vaccination

COVID-19 vaccination providers must document vaccine administration in their medical record systems within 24 hours of administration and use their best efforts to report administration data to the relevant system for the jurisdiction (i.e., immunization information system) as soon as practicable and no later than 72 hours after administration.

Storage and Handling Overview
weather icon

Store vaccine in a refrigerator. Do not freeze.

The vaccine will arrive at a refrigerated temperature of 2°C to 8°C (36°F and 46°F).

  • Unpack the vaccine shipment following the manufacturer’s directions.
    • Check both temperature monitoring devices in the box (3M MonitorMark and FreezeMark).
  • An ancillary supply kit will arrive separately from the vaccine.
How to Store the Janssen COVID-19 Vaccine
comment alt lines light icon
Report Adverse Events

Adverse events that occur in a recipient after COVID-19 vaccination are required to be reported to the Vaccine Adverse Event Reporting System (VAERS). FDA requires vaccination providers to report vaccine administration errors, serious adverse events, cases of multisystem inflammatory syndrome, and cases of COVID-19 that result in hospitalization or death after administration of COVID-19 vaccine under an EUA. Reporting is encouraged for other clinically significant adverse events, even if it is not clear that a vaccine caused the adverse event. Complete and submit reports to VAERS onlineexternal icon.

For further assistance with reporting to VAERS, call 1-800-822-7967.

hand holding medical light icon
What to Expect after a COVID-19 Vaccination

Print informationpdf icon for your patients on common side effects, helpful tips, and when to call a doctor after a COVID-19 vaccination.

email_03Get Email Updates

To receive email updates about this page, enter your email address:

Page last reviewed: March 11, 2021